Search results for "Premedication"

showing 10 items of 41 documents

Comparison of the brainstem auditory evoked responses during sevoflurane or alfaxalone anaesthesia in adult cats.

2017

Abstract Objective To compare the effects of general anaesthesia using sevoflurane or alfaxalone on the brainstem auditory evoked response (BAER) test in adult healthy cats. Study design Prospective, clinical, ‘blinded’, crossover study. Animals Ten feral adult healthy cats. Methods Premedication consisted of dexmedetomidine (0.01 mg kg –1 ) intramuscularly (IM). The first general anaesthesia was induced and maintained with sevoflurane (treatment S) for physical examination, BAER test, complete blood tests, thoracic radiographs and abdominal ultrasound. The second general anaesthesia was induced with alfaxalone (treatment A) IM (2 mg kg –1 ) and maintained with alfaxalone (10 mg kg –1 hour …

MaleMethyl Ethers040301 veterinary sciencesSevofluranePregnanediones0403 veterinary science03 medical and health sciencesSevoflurane0302 clinical medicine030202 anesthesiologymedicineEvoked Potentials Auditory Brain StemReaction TimeAnimalsGeneral anaesthesiaDexmedetomidineAnestheticsCATSCross-Over StudiesGeneral Veterinarybusiness.industryAlfaxalone04 agricultural and veterinary sciencesCrossover studyAuditory brainstem responseAnesthesiaCatsPremedicationbusinessmedicine.drugVeterinary anaesthesia and analgesia
researchProduct

Pretreatment with prasugrel in non-ST-segment elevation acute coronary syndromes

2013

Item does not contain fulltext BACKGROUND: Although P2Y12 antagonists are effective in patients with non-ST-segment elevation (NSTE) acute coronary syndromes, the effect of the timing of administration--before or after coronary angiography--is not known. We evaluated the effect of administering the P2Y12 antagonist prasugrel at the time of diagnosis versus administering it after the coronary angiography if percutaneous coronary intervention (PCI) was indicated. METHODS: We enrolled 4033 patients with NSTE acute coronary syndromes and a positive troponin level who were scheduled to undergo coronary angiography within 2 to 48 hours after randomization. Patients were randomly assigned to recei…

Malemedicine.medical_specialtyAcute coronary syndromePrasugrelmedicine.medical_treatmentPremedicationMyocardial InfarctionHemorrhageThiophenesCoronary AngiographyPiperazinesPercutaneous Coronary InterventionDouble-Blind MethodInternal medicinemedicineHumansMyocardial infarctionAcute Coronary SyndromeCoronary Artery BypassAgedCardiovascular diseases [NCEBP 14]business.industryMedicine (all)Hazard ratioAcute Coronary Syndrome; Aged; Coronary Artery Bypass; Double-Blind Method; Female; Hemorrhage; Humans; Male; Middle Aged; Myocardial Infarction; Percutaneous Coronary Intervention; Piperazines; Prasugrel Hydrochloride; Purinergic P2Y Receptor Antagonists; Thiophenes; Coronary Angiography; Premedication; Medicine (all)Percutaneous coronary interventionGeneral MedicineThrombolysisMiddle Agedta3121medicine.diseaseConventional PCICardiologyPurinergic P2Y Receptor AntagonistsFemalebusinessPrasugrel HydrochlorideTIMImedicine.drug
researchProduct

Oral chloral hydrate provides effective and safe sedation in paediatric magnetic resonance imaging.

1994

SUMMARY Sedation is routinely required for successful Magnetic Resonance imaging in infants and children. Five hundred and ninety-six paediatric patients (270 female and 326 male, age (mean±SD) 41±30 months and weight 14.8±6.5 kg) entered an open, non-comparative, prospective study to assess oral chloral hydrate sedation in a large and homogeneous paediatric population undergoing Magnetic Resonance imaging. Chloral hydrate syrup 70 mg/ml was administered 20–40 min prior to the procedure. Effective sedation was reached in 94.1% with a total dose (mean±SEM) of 68±1 mg/kg (range 20–170 mg/kg). Statistical analysis of sedation failures vs. successful examinations after the total dose showed sig…

Malemedicine.medical_specialtyAdolescentNauseamedicine.drug_classSedationPremedicationChloral hydrateConscious SedationAdministration OralOral administrationmedicineHumansPharmacology (medical)Chloral HydrateProspective StudiesProspective cohort studyChildPharmacologymedicine.diagnostic_testDose-Response Relationship Drugbusiness.industryInfantMagnetic resonance imagingMagnetic Resonance ImagingSurgerySedativeAnesthesiaChild PreschoolData Interpretation StatisticalVomitingDrug EvaluationFemalemedicine.symptombusinessmedicine.drugJournal of clinical pharmacy and therapeutics
researchProduct

Clinic modelling randomised trials (CMRT's) in animals as a new intermediate between biological experiments and randomised clinical trials: applicati…

1998

Malemedicine.medical_specialtySwinemedicine.medical_treatmentPremedicationImmunologyPharmacology toxicologyRanitidineHistamine ReleaseDouble-Blind MethodMedicineAnimalsDimethindenep-Methoxy-N-methylphenethylamineAnesthesiaCluster randomised controlled trialIntensive care medicineIntraoperative ComplicationsRandomized Controlled Trials as TopicPharmacologybusiness.industryClinical trialDisease Models AnimalHistamine H2 AntagonistsSurgical Procedures OperativeHistamine H1 AntagonistsSwine MiniatureAntihistamineFemalebusinessCimetidineInflammation research : official journal of the European Histamine Research Society ... [et al.]
researchProduct

Bleeding prophylaxis in a child with cleft palate and factor VII deficiency: a case report.

2006

Bleeding prophylaxis in a child with cleft palate and factor VII deficiency: a case report. Pirrello R, Siragusa S, Giambona C, D'Arpa S, Cordova A, Moschella F. Source Dipartimento di Discipline Chirurgiche ed Oncologiche, Sezione di Chirurgia Plastica e Ricostruttiva, Università di Palermo, Palermo, Italy. Abstract The association between factor VII deficiency and cleft palate has never been described. The case of a child with cleft palate and factor VII deficiency who successfully underwent palatoplasty is described in this article. To allow surgical treatment, through maintenance of a normal prothrombin time, the patient was given 15 microg/kg of recombinant factor VIIa every 12 hours, …

Malemedicine.medical_specialtymedicine.medical_treatmentFactor VII DeficiencyPremedicationBlood Loss SurgicalFactor VIIaPostoperative HemorrhageEfficacy03 medical and health scienceschemistry.chemical_compound0302 clinical medicineMedicineHumans030223 otorhinolaryngologyFactor VII deficiencyProthrombin timemedicine.diagnostic_testFactor VIIbiologybusiness.industryCoagulantsPalate030206 dentistryPerioperativePlastic Surgery ProceduresRecombinant ProteinsSurgeryCleft PalatePalatoplastyEl NiñochemistryOtorhinolaryngologyRecombinant factor VIIaAnesthesiaChild Preschoolbiology.proteinFACTOR VII DEFICIENCY CLEFT PALATE BLEEDING PROPHYLAXISProthrombin TimeOral SurgerybusinessThe Cleft palate-craniofacial journal : official publication of the American Cleft Palate-Craniofacial Association
researchProduct

Dental treatment of Marfan syndrome. With regard to a case.

2010

Marfan syndrome is the most common dominant autosomic genetic disorder of the connective tissue. It has a reported incidence of 1 per each 5000 individuals without any distinction of gender or ethnicity. This pathology?s diagnosis is mainly based on physical characteristics, presenting three main different symptomatic charts: neonatal Marfan, infant Marfan and classical Marfan. The mayor characteristic of these patients consists of an exaggerated length of the upper and lower limbs, hyperlaxity, scoliosis, alterations in the cardiovascular and pulmonary systems and atypical bone overgrowth. The individual implied in the present investigation concerned to a 14 year old male patient presentin…

Marfan syndromeMalemedicine.medical_specialtyPediatricsAdolescentLife qualityScoliosisMarfan SyndromemedicineHumansGeneral Dentistrybusiness.industryIncidence (epidemiology)Genetic disordermedicine.disease:CIENCIAS MÉDICAS [UNESCO]SurgeryOtorhinolaryngologyMale patientTooth DiseasesUNESCO::CIENCIAS MÉDICASAnxietySurgeryPremedicationmedicine.symptombusiness
researchProduct

A surgical model for isolating the pig liver in vivo for gene therapy.

2013

Several studies report results that suggest the need of vascularization blocking for efficient gene transfer to the liver, especially in nonviral gene therapy. In this study, we describe a surgical strategy for in vivo isolation of the pig liver, resulting in a vascular watertight organ that allows the evaluation of several gene injection conditions. The hepatic artery and portal, suprahepatic and infrahepatic cava veins were dissected. Then, liver vascularization was excluded for 5-7 min. In that time, we first injected 200 ml saline solution containing the p3c-eGFP plasmid (20 µg/ml) simultaneously through two different catheters placed in the portal and cava veins, respectively. Vital co…

Models AnatomicPathologymedicine.medical_specialtySwinemedicine.medical_treatmentGenetic enhancementPremedicationGreen Fluorescent ProteinsGene deliveryAndrologyIn vivomedicineAnimalsAspartate AminotransferasesSalineGenebusiness.industryHemodynamicsRNAAlanine TransaminaseGenetic Therapymedicine.anatomical_structureLiverSurgeryFemalebusinessPerfusionArtery
researchProduct

Adequate analgesia and sedation should be given to neonates during non‐emergency endotracheal intubation

2019

Nociceptionbusiness.industryPremedicationSedationInfant NewbornMEDLINEEndotracheal intubationGeneral MedicineAnesthesiaPediatrics Perinatology and Child HealthIntubation IntratrachealHumansMedicineNeonatologymedicine.symptombusinessActa Paediatrica
researchProduct

A pilot study demonstrating how inhaled furosemide enhances the bronchodilator effect of salbutamol

1993

Abstract To investigate whether inhaled furosemide can improve the bronchodilator effect of salbutamol, a single-blind crossover study in 10 subjects with stable asthma was designed. Each subject inhaled two puffs of salbutamol (200 μg) 1 hour after premedication with an aerosol preparation of either furosemide or placebo. Forced expiratory volume in 1 second (FEV 1 ) was measured before premedication, again before inhalation of salbutamol, and again 30, 60, and 90 minutes after, and 2, 3, 4, and 5 hours after inhalation of salbutamol. The FEV 1 at each time interval was greater on furosemide days but the difference was significant at 1, 4, and 5 hours after salbutamol inhalation. The areas…

PharmacologyInhalationbusiness.industrymedicine.drug_classFurosemiderespiratory systemmedicine.diseasePlaceboCrossover studyrespiratory tract diseasesBronchodilatorAnesthesiaSalbutamolMedicinePharmacology (medical)Premedicationbusinesscirculatory and respiratory physiologymedicine.drugAsthmaCurrent Therapeutic Research
researchProduct

Premedication with oral solution of simethicone plus N-acetylcysteine to improve the quality upper GI endoscopy: Initial experience

2020

Introduction: To assess the efficacy and safety of simethicone with or without N-acetylcysteine (NAC) as premedications before gastroscopy. Materials and methods: Patients were randomized into 5 groups. Endoscopic visibility was evaluated in 4 districts (esophagus, gastric body, fundus and antrum) using a visual scale, graduating from 1 to 4 points. Results: There was no significant difference on the rate of positive findings when comparing simethicone with simethicone plus NAC and with water, respectively. Simethicone plus NAC showed better total mucosal visibility score than simethicone alone. Both simethicone plus NAC and simethicone alone offer more benefit than water. The procedure tim…

PremedicationGastroscopySimethiconeQualityN-acetylcysteine
researchProduct